Drug Transport Agreement: Recombinant Erythropoietin Injector

Mail

Delivered as a mail message. Its text appears all at once, up to its first objective.

Drug Transport Agreement

Browse missions Show directory

Mission path

How to unlock

Complete every required branch below. Each row shows a full path from a known starting mission.

Required branchPrescription Drugs

Required

Communication Established Preliminary Investigation In-Depth Investigation Second Batch of Supplies Core Area Acquiring Experimental Data Operations Department (Private Channel): Wendigo Investigation Report Access to the Restricted Area Exchange of Favors Prescription Drugs

All required branches converge here

Current missionDrug Transport Agreement: Recombinant Erythropoietin InjectorU.R.C Research and Development Department · Mail mission

What this unlocks

This mission does not unlock another mission.

Requirements and rewards

Requirements

Collect: Crimson Reagent (Quantity: 5)

Rewards

Shop stock unlocked
- 1 × Erythropoietin Syrette

Quest content

Localized mission dialogue and instructions.

Drug Transport Agreement =================== License ID: EPO - 1709212 - 004 Name: Recombinant Erythropoietin Injector Specifications: Single-dose injector Primary Ingredients: Highly active recombinant erythropoietin and hematopoietic microenvironment enhancers. Description: Stimulates hematopoietic stem cell activity to produce red blood cells, replenishing lost blood from injuries and restoring vitality. =================== Procurement Request: Crimson Reagent x5

> [user]: Procurement request submitted.

> [U.R.C. R&D Department - Procurement Office]: The applicant's request is deemed reasonable, and has appropriate conditions for drug storage and usage. Approval granted for the procurement request for Recombinant Erythropoietin Injectors.